Azenta Inc (AZTA) USD0.01

Sell:$25.06Buy:$25.16Price decreased$0.38 (1.49%)

NASDAQ:Price increased0.85%
Market closed |
Prices delayed by at least 15 minutes
Sell:$25.06
Buy:$25.16
Change:Price decreased$0.38 (1.49%)
Market closed |
Prices delayed by at least 15 minutes
Sell:$25.06
Buy:$25.16
Change:Price decreased$0.38 (1.49%)
Market closed |
Prices delayed by at least 15 minutes

Company Information

About this company

Azenta, Inc. is a global provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The Company develops solutions for automated ultra-cold storage. It operates through two segments, which include Sample Management Solutions and Multiomics. The Sample Management Solutions segment operates as a single business unit offering end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The Multiomics segment operates as a single business unit offering genomic and other sample analysis services, including gene sequencing, gene synthesis and related services. It offers a portfolio of products and sample services including procurement, automated storage systems, genomic services and a multitude of sample consumables, informatics and data software.

Key people

Frank E. Casal
Independent Chairman of the Board
Quentin G. Koffey
Independent Director
John P. Marotta
President, Chief Executive Officer, Director
Lawrence Y. Lin
Chief Financial Officer, Executive Vice President
William E. Martin
President - Multiomics
Olga Pirogova
Chief Human Resources Officer, Senior Vice President
Ephraim Starr
Senior Vice President, General Counsel, Corporate Secretary
William L. Cornog
Independent Director
Robyn C. Davis
Independent Director
Dipal Doshi
Independent Director
Click to see more

Key facts

  • Shares in issue
    59.55m
  • EPIC
    AZTA
  • ISIN
    US1143401024
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • Market cap
    $1.18bn
  • Employees
    3,000
  • Exchange
    NASDAQ
  • Index
    S&P 600 Small Cap, TR Equity United States Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.